CIPO Patents = 1

EPO Patents = 4

Forward Citations = 23

Loading Chart...

5 inventors (with patents filed for the assignee):

Rebecca Jane Thorne (5 out of 5 patents)

Bruce B Campbell (3 out of 3 patents)

D Lansing Taylor (2 out of 23 patents)

4. Kenneth A Giuliano (2 out of 13 patents)

5. Albert H Gough (2 out of 10 patents)

7 patents: Sort by Forward Citations

1. 12442819 - Methods of predicting progression of Barrett's esophagus (2025-10-14),

2. 12372527 - Systems and compositions for diagnosing Barrett's esophagus and methods of using the same (2025-07-29),

3. 11221333 - Systems and compositions for diagnosing Barrett's esophagus and methods of using the same (2022-01-11),

4. 10962544 - Methods of predicting progression of Barrett's esophagus (2021-03-30),

5. 10018631 - Systems and compositions for diagnosing Barrett's esophagus and methods of using the same (2018-07-10),

6. 8597899 - Method for automated tissue analysis (2013-12-03),

7. 8114615 - Method for automated tissue analysis (2012-02-14),

Cernostics, Inc. is a biotechnology company that focuses on the development of innovative molecular diagnostics for the early detection of cancer. Their flagship product, TissueCypher, is a precision diagnostic test designed to accurately predict an individual's risk of developing esophageal cancer. Cernostics is dedicated to improving patient outcomes and reducing healthcare costs through advanced diagnostic technology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#30 in Bethlehem, PA

#1,438 in Pennsylvania

#39,879 in US

Bethlehem, PA, United States of America

Cernostics, Inc.

Forward Citations = 23

5 inventors:

Rebecca Jane Thorne (5 out of 5 patents)

Bruce B Campbell (3 out of 3 patents)

D Lansing Taylor (2 out of 23 patents)

4. Kenneth A Giuliano (2 out of 13 patents)

5. Albert H Gough (2 out of 10 patents)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

4 patents (EPO):

Please report any incorrect information to [email protected]